An Alzheimer's drug developed by Swiss company Roche could not be proven in clinical trials to slow the progression of dementia, the pharmaceutical giant said Monday.
In a statement, Roche said the drug, gantenerumab, "did not meet their primary endpoint of slowing clinical decline" in a pair of studies conducted by the company. The identical studies, which were conducted with patients over the course of two years, were held in an effort to prove that gantenerumab could preserve certain functions in early Alzheimer's patients, including problem-solving skills, memory, and judgment.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
G20: Viola Davis stars in 'ludicrous' but fun action thrillerThe Week Recommends The award-winning actress plays the 'swashbuckling American president' in this newly released Prime Video film
-
The Masters: Rory McIlroy finally banishes his demonsIn the Spotlight McIlroy's grand slam triumph will go down as 'one of the greatest and most courageous victories in the history of golf'
-
What is your net worth and why is it worth knowing?the explainer Take stock of your assets
-
RFK Jr. visits Texas as 2nd child dies from measlesSpeed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
What does Health and Human Services do?The Explainer Cuts will 'dramatically alter' public health in America
-
Shingles vaccine cuts dementia risk, study findsSpeed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
-
Tuberculosis sees a resurgence and is only going to get worseUnder the radar The spread of the deadly infection is buoyed by global unrest
-
Measles outbreak spreads, as does RFK Jr.'s influenceSpeed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
-
The strange phenomenon of beard transplantsIn The Spotlight Inquiries for the procedure have tripled since 2020, according to one clinician, as prospective patients reportedly seek a more 'masculine' look
-
Poor sleep may make you more prone to believing conspiracy theoriesUnder the radar Catch z's for society
-
RFK Jr. offers alternative remedies as measles spreadsSpeed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
